Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection

[1]  T. Lion,et al.  Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation. , 1999, Cytotherapy.

[2]  C. Perreault,et al.  Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease. , 1998, Experimental hematology.

[3]  H. Einsele,et al.  Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT , 1998, Bone Marrow Transplantation.

[4]  A. Nagler,et al.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.

[5]  S. Forman.  Stem cell transplantation in acute leukemia , 1998, Current opinion in oncology.

[6]  R. Miniero,et al.  Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation , 1997, Bone Marrow Transplantation.

[7]  T. Klingebiel,et al.  Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse? , 1997, Bone Marrow Transplantation.

[8]  S. Singhal,et al.  Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts , 1997, Bone Marrow Transplantation.

[9]  E. Trabetti,et al.  Early detection of bone marrow engraftment by amplification of hypervariable DNA regions. , 1997, Haematologica.

[10]  M. Velasco,et al.  Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. , 1996, Bone marrow transplantation.

[11]  J. Wang-Rodriguez,et al.  Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats , 1996, American journal of hematology.

[12]  C. Perreault,et al.  Sequential analysis of early hematopoietic reconstitution following allogeneic bone marrow transplantation with fluorescence in situ hybridization (FISH). , 1996, Bone marrow transplantation.

[13]  T. Lion.  Monitoring of residual disease in chronic myelogenous leukemia: methodological approaches and clinical aspects. , 1996, Leukemia.

[14]  J. Briones,et al.  Study of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR amplification of short tandem repeats , 1996, Annals of Hematology.

[15]  M. Potter,et al.  Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. , 1996, Blood.

[16]  J. Schumm,et al.  General approach to analysis of polymorphic short tandem repeat loci. , 1996, BioTechniques.

[17]  P. Wernet,et al.  Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse. , 1996, Cancer detection and prevention.

[18]  M. Caligiuri,et al.  Description of an efficient and highly informative method for the evaluation of hematopoietic chimerism following allogeneic bone marrow transplantation. , 1995, Bone marrow transplantation.

[19]  G. Socié,et al.  Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era. , 1995, Leukemia research.

[20]  C. McFarland,et al.  Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. , 1995, Blood.

[21]  F. Aversa,et al.  Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. , 1994, Blood.

[22]  J. Bourhis,et al.  Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non−T-cell−depleted bone marrow transplantation , 1994 .

[23]  J. Wijnen,et al.  Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. , 1994, Blood.

[24]  R. Herrmann,et al.  Very early analysis of graft establishment after allogeneic bone marrow transplantation using the polymerase chain reaction , 1993, British journal of haematology.

[25]  N. Schmitz,et al.  Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms. , 1993, Leukemia.

[26]  T. Lion,et al.  Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia , 1993, The Lancet.

[27]  T. Lion,et al.  Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. , 1992, Leukemia.

[28]  D. Ginsburg,et al.  USE OF POLYMERASE CHAIN REACTION‐DETECTED SEQUENCE POLYMORPHISMS TO DOCUMENT ENGRAFTMENT FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION , 1990, Transplantation.

[29]  J. Kurtzberg,et al.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.